Professor Elizabeth Simpson FRS
Senior Research Investigator
Department of Medicine
Tel: +44 (0)20 3313 1967
Professor Elizabeth Simpson
1960 - Cambridge University - BA, Natural Sciences,
1963 - Cambridge University, Veterinary School - VetMB
1964 - Cambridge University - MA
1999 - Elected Fellow of Academy of Medical Sciences, London
2010 - Elected honorary Fellow of the Royal Veterinary College
2010 - Elected Fellow of the Royal Society
2004 – present, Emeritus Professor of Transplantation Biology,
1999 – 2004, Deputy Director, Clinical Sciences Centre, IC
1984 – 2004 - Head, Transplantation Biology Group, Clinical Research Centre, Harrow and, since 1994, at the Clinical Sciences Centre, Hammersmith Hospital, RPMS/IC
1971-1984 - Research Scientist in Section of Transplantation
USA 1972-1973 - Visiting Associate, Immunology Branch, National Cancer Institute, NIH, Bethesda, Maryland, USA.
1976 – present - Summer visiting scientist, Jax Laboratory, USA
1969-1971 - Research scientist at NIMR, Mill Hill London, NW7
1970-1971 - WHO Consultant Immunologist, NICD, Delhi, India.
1966-1969 - Assistant Lecturer, Animal Pathology, Cambridge
1965-1966 - Virologist, Department of Health and Welfare, Ottawa,
1963-1965 - Veterinary surgeon, private practice, NB, Canada.
Sometime member Editorial Boards
Eur J Imm, Transplantation, Cellular Immunology, Immunology,
Immunogenetics, Scandinavian Journal of Immunology
Transmitting editor, International Immunology
Referee for: Nature, Cell, Journal of Immunology, PNAS, Immunity, Science, Proc.Natl.Acad.Sci., Blood, BJC and others.
MRC: Cell Board member 1983-87
Cell Board A Grants Committee Chairman, 1984-87
MRC Animals Research Committee member 1993 - 2003
AFRC: Animals Research Grants Boards member 1989-1992
Cancer Research Campaign: Grants Committee member 1992-01
Scientific Committee member 2000-2002
Cancer Research UK: Programmes Committee member 2002-2006
Projects Committee Chairman 2003-2006
Scientific Executive Board member 2004-2006
Fellowships interview panel member 2002-2007
Wellcome Trust: Infection and Immunity Panel member 1992-1997
Genetics Interest Group member 1993-1998
Clinical Research fellowship panel - member 2006-present
Veterinary Research fellowship panel Chairman 2007- present
Roslin Institute Director’s Advisory Board member 1994-2001
Cobra Therapeutics Ltd. Scientific Advisory Board 1998-2000
Gensel: Scientific Advisory Board, 1999-2001
Royal Society: Dorothy Hodgkin Fellowship panel member 2005-10
Government of South Korea: science funding advisor, 2006-2012
The molecular nature of epitopes recognised by T cells with particular reference to transplantation, autoimmunity and tumour immunity; the genetic control of immune responses to T cell epitopes with respect to MHC and non-MHC linked genes.
C1q enhances IFN-gamma production by antigen-specific T cells via the CD40 costimulatory pathway on dendritic cell . Baruah P, Dumitriu IE, Malik TH, Cook HT, Dyson J, Scott D, Simpson E, Botto M. Blood. 2009 113:3485-93.
Concomitant Tumor and Minor Histocompatibility Antigen-Specific Immunity Initiate Rejection and Maintain Remission from Established Spontaneous Solid Tumors. Hess Michelini R, Freschi M, Manzo T, Jachetti E, Degl'innocenti E, Grioni M, Basso V, Bonini C, Simpson E, Mondino A, et al. Cancer Res 2010 70:3505-14
Mice lacking C1q or C3 show accelerated rejection of minor H disparate skin grafts and resistance to induction of tolerance. Baruah P, Simpson E, Dumitriu IE, Derbyshire K, Coe D, Addey C, Dyson J, Chai JG, Cook T, Scott D, et al.Botto M Eur J Immunol 2010 40:1758-1767
The roles of antigen-specificity, responsiveness to TGFβ and APC subsets in tumour-induced expansion of regulatory T cells. Coe, David; Addey, Caroline; White, Matthew; Simpson, Elizabeth; Dyson, P J; Chai, JG. Immunology, in press 2010
- Manzo T; Hess Michelini R; Basso V; Ricupito A; Chai JG; Simpson E; Bellone M; Mondino A. (1 Feb 2011). Concurrent allorecognition has a limited impact on posttransplant vaccination. J Immunol. 186:1361-1368. Author weblink DOI.
- Hess Michelini R; Freschi M; Manzo T; Jachetti E; Degl'Innocenti E; Grioni M; Basso V; Bonini C; et alSimpson E; Mondino A; Bellone M. (1 May 2010). Concomitant tumor and minor histocompatibility antigen-specific immunity initiate rejection and maintain remission from established spontaneous solid tumors. Cancer Res. 70:3505-3514. Author weblink DOI.
- Baruah P; Simpson E; Dumitriu IE; Derbyshire K; Coe D; Addey C; Dyson J; Chai JG; et alCook T; Scott D; Botto M. (Jun 2010). Mice lacking C1q or C3 show accelerated rejection of minor H disparate skin grafts and resistance to induction of tolerance. Eur J Immunol. 40:1758-1767. Author weblink DOI.
- Baruah P; Dumitriu IE; Malik TH; Cook HT; Dyson J; Scott D; Simpson E; Botto M. (9 Apr 2009). C1q enhances IFN-gamma production by antigen-specific T cells via the CD40 costimulatory pathway on dendritic cells. BLOOD. 113:3485-3493. Author weblink DOI.
- Greenlaw RE; Gardner NJ; Farrar CA; Shariff H; Sacks SH; Yagita H; Simpson E; Jurcevic S. (1 Nov 2008). An antibody combination that targets activated T cells extends graft survival in sensitized recipients. AMERICAN JOURNAL OF TRANSPLANTATION. 8:2272-2282. Author weblink DOI.
- Chai J-G; Coe D; Chen D; Simpson E; Dyson J; Scott D. (15 Jan 2008). In vitro expansion improves in vivo regulation by CD4(+)CD25(+) regulatory T cells. JOURNAL OF IMMUNOLOGY. 180:858-869. Author weblink.